Table 2.

Type of P2Y12 inhibitor associated with aspirin at enrolment and after cardiologist' assessment according to the time from last MI (12‐24 months vs 24‐36 months)

		Time from MI
		12‐24 months	25‐36 months
DAPT at enrolment	Clopidogrel	188 (45.5%)	114 (79.2%)
N = 557
	Prasugrel	60 (14.5%)	5 (3.5%)
	Ticagrelor 90 mg bid	143 (34.6%)	21 (14.6%)
	Ticagrelor 60 mg bid	20 (4.8%)	3 (0.2%)
	Ticlopidine	2 (0.5%)	1 (0.1%)
	Total	413	144
DAPT after cardiologist assessment	Clopidogrel	177 (55.8%)	112 (84.2%)
N = 450
	Prasugrel	27 (8.5%)	2 (1.5%)
	Ticagrelor 90 mg bid	64 (20.2%)	15 (11.3%)
	Ticagrelor 60 mg bid	47 (14.8%)	3 (2.3%)
	Ticlopidine	2 (0.6%)	1 (0.8%)
	Total	317	133